SCHEMBL23964018

SCHEMBL23964018

CC1CN(C(=O)OC(C)(C)C)C[C@H]1CF

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.50
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
USP30 Q70CQ3 2/20 0.40
NAMPT P43490 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
RORC P51449 1/20 0.39
KAT6A Q92794 1/20 0.37
KAT8 Q9H7Z6 1/20 0.37
RECQL P46063 1/20 0.37
EPHX1 P07099 1/20 0.37
PDE4B Q07343 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16080210 0.89 NR1H2 (0.49) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL30456121 0.87 NR1H2 (0.50) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL21603201 0.86 NR1H2 (0.53) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL25617959 0.86 NR1H2 (0.53) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL12683334 0.86 NR1H2 (0.53) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL16472381 0.86 NR1H2 (0.53) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL13177350 0.85 NR1H2 (0.59) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL29128147 0.85 NR1H2 (0.59) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL14800658 0.85 NR1H2 (0.59) NR1H2USP2SMN1; SMN2USP30NAMPT
SCHEMBL14800656 0.85 NR1H2 (0.59) NR1H2USP2SMN1; SMN2USP30NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed